Eli Lilly’s drug baricitinib, sold under the brand name Olumiant, prevented 1 death for every 6 patients on a ventilator in a phase 3 clinical trial, the drugmaker said Aug. 3. The trial, which ...
Eli Lilly shared results for its drug Verzenio, showing it reduced the risk of death by 15% when combined with endocrine therapy for patients with a certain kind of breast cancer. The results are from ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback